Abstract
Introduction
T cell apoptosis has been suggested to play an important activation or Fas-induced apoptosis has not yet been elucidated. A number of studies have suggested that cross-linking role in the pathogenesis of HIV disease by contributing to the loss of T cell numbers and function (1). We recently showed of CD4 on T cells by gp120 protein results in T cells undergoing AICD when this cross-linking is followed with stimulation that peripheral blood T cells in HIV ϩ individuals are especially prone to undergo apoptosis in response to Fas antigen through the TCR (5, 7) . Recent reports have shown that Tat primes normal peripheral blood T cells to undergo spontanstimulation (2). Activation-induced cell death (AICD) of peripheral blood T cells, which has also been described in HIV ϩ eous apoptosis or AICD in response to TCR or anti-CD3 stimulation (8) (9) (10) ; however, the role of Tat in priming T cells individuals (3) (4) (5) , we found is Fas independent (6) , suggesting that these two mechanisms of apoptosis may play different to undergo Fas-induced apoptosis is not clear. Tat may also play an important role in the defective proliferative T cell pathogenic roles.
The mechanism, however, of such T cell priming to undergo responses observed in HIV infection (1), as Tat has been shown to inhibit antigen-specific proliferative responses of transferred to plates coated with immobilized anti-Fas or isotype control antibody. Specific anti-Fas-induced apoptosis human peripheral blood T cells (10, 11) . This immunosupressive effect has been attributed to the inhibition of IL-2 producwas calculated by subtracting the isotype control-induced apoptosis from the anti-Fas-induced apoptosis under identical tion and IL-2 receptor α chain expression which is observed in Tat-transfected Jurkat T cells (12) . However, in light of recent conditions, i.e. specific anti-Fas CD4 ϩ or CD8 ϩ T cell apoptosis of Tat/anti-CD3 combination pretreated PBMC ϭ reports (8, 9) , Tat may also inhibit proliferative responses via its enhancing effect on activation-induced T cell apoptosis.
(anti-Fas-induced CD4 ϩ or CD8 ϩ apoptosis of Tat/anti-CD3 pretreated PBMC) -(isotype control-induced CD4 ϩ or CD8 ϩ In this report we show that Tat enhances activation-induced apoptosis of peripheral blood CD4 ϩ and CD8 ϩ T cells but apoptosis of Tat/anti-CD3 pretreated PBMC). In all the above experiments cells were cultured for 24 h at 1ϫ10 6 cells/ml/ does not prime T cells to undergo Fas-induced apoptosis. These findings suggest that Tat may contribute to some, but well in RPMI 1640/10% FCS in 24-well plates. not all, aspects of T cell apoptosis in HIV disease. Investigating
Effect of rotenone or TMPO on Tat-induced apoptosis the mechanism by which Tat may exert its effect, we found Freshly isolated PBMC were cultured with rotenone or TMPO that Tat induces marked apoptosis when ROI generation is at 500 nM and 40 mM respectively in the presence or absence inhibited or ROI are neutralized. Elucidating the mechanisms of Tat protein for 24 h. For the ICE inhibitor experiments PBMC of T cell priming to undergo activation and Fas-induced were first preincubated for 3 h with 50 µM z-VAD-fmk or zapoptosis may prove useful in designing novel strategies to FA-fmk at 37°C and then cells were treated with rotenone or prevent T cell depletion and restore the functional defects TMPO and Tat. PBMC were cultured at 10 6 cells/ml at 37°C observed in HIV disease.
in a 5% CO 2 incubator. Following 24 h of culture, cells were harvested and stained as above.
Methods
Apoptosis measurement and DNA fragmentation Samples and materials Apoptosis was determined by FACS analysis, as previously described (2) determined by multiplying the fraction of live non-apoptotic as previously described (13, 14) . The control p51 protein, CD4 ϩ and CD8 ϩ T cells in culture (determined by flow recombinant polyhistidinylated p51 subunit of HIV-1 reverse cytometry) times the total number of PBMC in culture meastranscriptase, was similarly prepared as above. Rotenone, an ured by a Coulter Counter model ZM (Coulter, Hialeah, FL). inhibitor of complex I of the respiratory chain (15, 16) , and DNA fragmentation was examined by gel electrophoresis. 3,3,5,5-tetramethylpyrroline N-oxide (TMPO), a free radical PBMC (2ϫ10 6 cells) were treated in culture as described spin trap (17) , were both commercially purchased (Sigma, St above for 5 h, cells were centrifuged and DNA was extracted Louis, MO). The tripeptide ICE inhibitor z-VAD-fmk (fluoroby resuspending cells in 20 µl of 50 mM Tris-HCl, pH 8.0, methylketone) and the control dipeptide z-FA-fmk were com-10 mM EDTA, 0.5% sodium lauryl sarcosylate, 0.5 mg/ml mercially purchased (Enzyme Systems Products, Dublin, CA).
proteinase K and incubated for 1 h at 50°C. RNase was then Tat priming experiments and anti-Fas-and anti-CD3-induced added at 100 µg/ml and the extract was further digested for apoptosis.
1 h at 50°C. DNA was run on a 2% agarose gel in 45 mM Tris borate, 1 mM EDTA, pH 8.0, stained with 0.5 µg/ml Peripheral blood mononuclear cells (PBMC) were isolated ethidium bromide and visualized under UV light. from buffy coats by density centrifugation on Ficol-Hypaque and were cultured for 24 h at 1ϫ10 6 cells/ml in RPMI 1640/ Statistical analysis 10% FCS in 24-well plates coated with or without 1 µM Tat or Data were analyzed by Mann-Whitney U-test and Wilcoxon's p51 protein in the presence or absence of immobilized signed-rank test for paired data, using JMP Statistics Guide monoclonal anti-Fas antibody M3, anti-CD3 antibody OKT3
(SAS Institute, Cary, NC). or isotype control IgG1 mAb DS-1. Plates were coated with 500 µl/well of 10 µg/ml of antibodies in RPMI 1640 for 2 h at 37°C, plates were then washed twice briefly with 500 µl/well Results RPMI 1640/10% FCS and then washed one more time as
Tat enhances AICD of normal T cells above for 30 min at 37°C. In the Fas priming experiments PBMC were first cultured with or without 1 µM Tat/p51 and Using multiparameter flow cytometry to measure apoptosis, we found that Tat protein enhances AICD of normal peripheral immobilized anti-CD3 or isotype control for 24 h, and then blood T cells. In concordance with previous reports (8,9), we found that anti-CD3-induced CD4 ϩ and CD8 ϩ T cell apoptosis Table 1 . Effect of Tat on Fas-induced apoptosis of peripheral in normal PBMC was enhanced by Tat protein in 24 h cultures.
blood T cells from healthy individuals (n ϭ 7) Anti-CD3-induced apoptosis was 11.5 Ϯ 3.5 and 8.2 Ϯ 2.4% for CD4 ϩ and CD8 ϩ T cells respectively, Tat enhanced antiPretreatment Apoptosis (%)
CD3-induced apoptosis to 26.3 Ϯ 6.9 and 27.3 Ϯ 6.5% for CD4 ϩ and CD8 ϩ T cells respectively (n ϭ 11, mean Ϯ SE not increase the spontaneous (no Tat treatment: 1.8 Ϯ 0.5 and 1.8 Ϯ 0.3%, Tat treatment: 2.3 Ϯ 0.6 and 1.9 Ϯ 0.4% for CD4 ϩ and CD8 ϩ T cells respectively, n ϭ 11) or isotype Tat does not enhance Fas-induced T cell apoptosis control-induced T cell apoptosis in these PBMC cultures (data not shown and Figs 1 and 2, and Table 1 ), indicating that Tat Pretreatment of PBMC with 1 µM Tat alone for 24 h did not affects only activation-induced T cell apoptosis and does not enhance specific anti-Fas-induced CD4 ϩ and CD8 ϩ T cell directly induce apoptosis in resting T cells. The control HIV apoptosis in 24 h cultures (Figs 3 and 4, and Table 1 ). Although protein p51 had no effect on neither spontaneous nor antiTat appeared to enhance anti-Fas-induced apoptosis when CD3 or isotype control antibody-induced apoptosis or cell cells are treated with Tat and anti-CD3 (Fas-induced apoptosis counts. Similarly with PBMC T cells, Jurkat T cell line antiof anti-CD3 pretreated cultures: 16.1 Ϯ 2.8 and 12 Ϯ 2.1 for CD3-induced apoptosis was also enhanced significantly by CD4 ϩ and CD8 ϩ T cells respectively; Fas-induced apoptosis Tat but not p51 protein (data not shown) and this is in of anti-CD3 ϩ Tat pretreated cultures: 24.8 Ϯ 4.9 and 21.4 Ϯ agreement with previously published work (9,13). Spontan-3.5% for CD4 ϩ and CD8 ϩ T cells respectively, n ϭ 7), this eous or isotype control-induced apoptosis of the Jurkat T cell enhancement is all due to the effect Tat has on anti-CD3-line was not enhanced by Tat or p51 control protein (data induced apoptosis, since a similar increase was also observed in apoptosis-induced by the isotype control antibody (Fig. 3  not shown) . 
Tat induces apoptosis when O 2 -superoxide anion generation is inhibited
Since it has been suggested that Tat may affect apoptosis by down-regulating Mn superoxide dismutase (MnSOD), thus altering the redox state of cells and lowering their reducing capacity (19, 20) , we investigated the effect of inhibiting the generation of ROI on Tat-induced apoptosis. Reagents that block the generation of ROI or neutralize ROI, such as rotenone, an inhibitor of complex I of the mitochondrial respiratory chain (15, 16) , and TMPO (17) , an electron spin (Fig. 5A) . Twenty-four hour apoptosis of CD4 ϩ T (n ϭ 7) of specific Fas-induced apoptosis shown. Mean and SE shown. cells was 4.8 Ϯ 0.45% in untreated cultures, 7.4 Ϯ 1.1% for 1 µM Tat alone treatment, 8.8 Ϯ 2.3% for 500 nM rotenone treatment, 6.8 Ϯ 1.2% for 40 mM TMPO treatment, 40.3 Ϯ 3.7% for 1 µM Tat plus 500 nM rotenone treatment and 56.1 Ϯ 3.4% 1 µM for Tat plus 40 mM TMPO treatment (n ϭ and Table 1 ). When specific anti-Fas apoptosis was calcu-7). CD8 ϩ T cell apoptosis was similar to the CD4 ϩ T cell lated, Tat did not significantly enhance specific anti-Fasresults (data not shown). Rotenone and TMPO also enhanced induced T cell apoptosis (Fig. 4) . Tat treatment also did not DNA fragmentation in Tat-treated PBMC cultures (Fig. 5B) . induce any significant effect on DNA fragmentation and cell Rotenone or TMPO alone did not induce any DNA fragmentanumbers in the anti-Fas treated cultures above those induced tion above background (data not shown). This effect of by anti-CD3 alone. Tat protein added simultaneously with rotenone and TMPO on Tat-induced apoptosis was shown to anti-Fas treatment also had no effect on Fas-induced be dose dependent (Fig. 6A and data not shown). apoptosis and cell counts in these cultures (data not shown).
In order to further elucidate the above, we also performed No effect on anti-Fas antibody-induced apoptosis was the rotenone/Tat and TMPO/Tat experiments in the presence observed either when cultures were preincubated for 3 days of an irreversible inhibitor of the ICE protease family. The with Tat alone or in combination with anti-CD3 (data not tripeptide inhibitor z-VAD-fmk inactivates ICE and is expected shown). These data taken collectively show that Tat enhances to inhibit other ICE-like proteases (21). z-VAD-fmk can inhibit anti-CD3-induced CD4 ϩ and CD8 ϩ T cell apoptosis but fails to have any effect on anti-Fas-induced apoptosis.
IL-1β secretion by lipopolysaccharide-stimulated monocytes peripheral blood T cells to undergo AICD (8, 9) . We have recently shown that peripheral blood T cells from HIV ϩ individuals undergo apoptosis in response to stimulation of Fas antigen (CD95) (2), this Fas-induced apoptosis preferentially kills CD4 ϩ compared to CD8 ϩ T cells, whereas anti-CD3 (P. Katsikis, unpublished observation), and can inhibit apoptosis-induced by Fas (P. Katsikis, unpublished observainduces apoptosis equally in both CD4 ϩ and CD8 ϩ T cells (6) , and is Fas independent (6). Fas-mediated apoptosis does tion) (22), overexpression of REAPER (23) and FLICE/MACH (24) and a variety of other stimuli (25, 26) . The ICE family not require T cells to engage with their respective antigen since activated cytotoxic CD8 ϩ T cells with up-regulated FasL homolog inhibitor z-VAD-fmk (50 µM) could not inhibit the enhanced Tat-induced apoptosis in neither rotenone-nor could kill bystander T cells. AICD, on the other hand, requires T cells to be activated following binding to their antigen. TMPO-treated cultures (Fig. 6B) . At this concentration z-VADfmk inhibits 80% of anti-Fas-induced apoptosis of the Jurkat These two mechanisms of apoptosis, Fas-mediated apoptosis of T cells and T cell AICD, may play different roles in the T cell line (data not shown). The control dipeptide z-FA-fmk had no effect in any of the above cultures (data not shown).
T cell depletion and dysfunction in HIV disease. The above findings suggest that activation and Fas-induced These findings clearly show that Tat can induce apoptosis by an ROI independent mechanism which is also ICE protease apoptosis may play different pathogenic roles in HIV disease (6) . If these two modes of apoptosis are independent one independent. This, however, does not exclude that other cysteine proteases, such as CPP32 which are not inactivated may expect that different apoptosis priming mechanisms may be responsible for T cell apoptosis in HIV disease. Tat by z-VAD-fmk (22), are involved in rotenone or TMPO enhancement of Tat-induced apoptosis.
protein has been suggested as one such priming mechanism, enhancing spontaneous or activation-induced T cell apoptosis (8) (9) (10) 13) . In our study we show that Tat enhances anti-CD3-Discussion induced CD4 ϩ and CD8 ϩ T cell apoptosis of normal peripheral blood T cells but does not affect spontaneous apoptosis. In The mechanism of priming of T cells for apoptosis in HIV disease has not yet been fully elucidated. Recent reports superantigen-stimulated T cells the apoptosis enhancing effect of Tat has been attributed to enhanced Fas ligand uphave suggested that Tat may be involved by priming normal regulation (9) . This, however, may not be universally true the Tat-induced down-regulation of MnSOD could be viewed as a strategy by which HIV virus secures maximal Tat transcripfor activation-induced T cell death as differences between superantigen and anti-CD3-induced apoptosis of T cells may tional activity in infected cells via NF-κB activation (19) whilst minimizing cell death induced by Tat. Although the above exist. Superantigen-induced T cell apoptosis has been shown to require Fas-Fas ligand interactions whereas anti-CD3-data do not directly address the enhancement of AICD by Tat, they do raise the possibility that Tat can induce apoptosis induced T cell death can proceed in the absence of Fas (27). We show here that Tat does not increase the number of T by a ROI independent mechanism. Although HIV-infected cells are prone to undergo apoptosis cells primed (sensitized) to undergo Fas-induced apoptosis. Therefore some other factor/mechanism is responsible for in response to stimulation of Fas (30), direct infection as a mechanism of priming for Fas-mediated apoptosis or AICD the increased Fas sensitivity/priming which is observed in peripheral blood T cells from HIV-infected individuals.
for peripheral blood T cells in HIV disease is excluded by the fact that the frequency of HIV-infected T cells in peripheral Inappropriate CD4 cross-linking on T cells by gp120 and antibodies to gp120 has been suggested as another mechanblood (31,32) is much lower than the levels of Fas-induced apoptosis or AICD (2,6). In addition a number of reports have ism that enhances activation-induced apoptosis in HIV disease (5, 7) . In one report the combination of CD4 crossshown that cells undergoing apoptosis in lymph nodes of HIV-infected individuals or the thymus of SCID mice reconstitlinking and Tat resulted in enhanced AICD, without increasing sensitivity to Fas-induced apoptosis (9) . In our hands, CD4 uted with human fetal thymus and liver are not infected with HIV virus (33,34). Therefore an indirect mechanism for priming cross-linking by the Leu3a monoclonal anti-CD4 antibody or recombinant gp120 Ϯ polyclonal anti-gp120 antibodies failed must be responsible for the enhanced T cell apoptosis in response to Fas stimulation or activation in HIV. Our results to induce spontaneous or enhance anti-CD3-or anti-Fasinduced T cell apoptosis of normal PBMC from healthy here show that Tat is not involved in the priming of T cells to undergo Fas-induced apoptosis but does enhance T cell individuals (P. Katsikis unpublished observations). The reason for such discrepancies remain unclear at the moment.
AICD. Thus the mechanism of priming of T cells in HIV infection to undergo Fas-mediated apoptosis remains elusive. A number of studies have suggested that Tat can inhibit apoptosis both when added in solution and when transfected Our study shows that Tat does not enhance the spontaneous apoptosis of normal T cells and the Jurkat T cell line. Although in a number of cell lines including the Jurkat T cell line (28,29). These studies have been performed with Tat-transfected cells Tat can enhance AICD of peripheral blood T cells from healthy individuals and the Jurkat T cell line it can neither prime cells cultured under low or no serum conditions. Tat may be acting via different mechanisms in this experimental set up, since Tat to undergo Fas-mediated apoptosis nor enhance Fas-induced apoptosis. Tat induced peripheral blood T cell apoptosis transfected Jurkats cultured in normal serum conditions show enhanced apoptosis (13) . In our study Tat added in solution to when O 2 -superoxide anion generation was inhibited or ROI were neutralized, raising the possibility that Tat under certain Jurkat cell resulted in enhanced AICD of these cells. These discrepancies are likely to be due to differences in cell cycling conditions may induce apoptosis by ROI independent mechanisms. Determining the mechanisms responsible for priming which result from culturing cells under different conditions, since it has been suggested that Tat mediates its effect on T cells to undergo Fas-mediated apoptosis in HIV may prove valuable in understanding the pathogenesis of HIV infection. apoptosis by activating cyclin-dependent kinases (8) .
Another possible mechanism by which Tat may induce apoptosis is by modulating the redox status of cells. Recently, Acknowledgements it has been shown that Tat down-regulates MnSOD, decreases
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